Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3657711rdf:typepubmed:Citationlld:pubmed
pubmed-article:3657711lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3657711lifeskim:mentionsumls-concept:C0027819lld:lifeskim
pubmed-article:3657711lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:3657711lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:3657711pubmed:issue4lld:pubmed
pubmed-article:3657711pubmed:dateCreated1987-11-6lld:pubmed
pubmed-article:3657711pubmed:abstractTextPoor results with 131I-meta-iodobenzylguanidine (MIBG) therapy have been obtained in two children with stage IV neuroblastoma treated after partial surgery and unsatisfactory combination chemotherapy. Both patients' response to treatment (four and three 1-month-spaced courses, respectively; cumulative administration of 11.9 and 9.2 GBq) has been characterized by a low isotope concentration in the primary tumor and in the multiple bone metastases and by bone marrow uptake with final severe hematological toxicity. A slight decrease in the primary tumor's volume was observed in one patient at a cumulative dose of 85 Gy; there was no change in the other's at 42 Gy. At an initial, greater isotope concentration delivering 103 Gy, some bone metastases displayed a sharp decrease in uptake that persisted in the successive courses. For both patients a progressive spreading of new tumor localisation in the bones and finally in the soft tissues was observed.lld:pubmed
pubmed-article:3657711pubmed:languageenglld:pubmed
pubmed-article:3657711pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3657711pubmed:citationSubsetIMlld:pubmed
pubmed-article:3657711pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3657711pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3657711pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3657711pubmed:statusMEDLINElld:pubmed
pubmed-article:3657711pubmed:issn0098-1532lld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:MussaG CGClld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:MadonEElld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:GraziaGGlld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:SilvestroLLlld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:FaveroAAlld:pubmed
pubmed-article:3657711pubmed:authorpubmed-author:CottinoFFlld:pubmed
pubmed-article:3657711pubmed:issnTypePrintlld:pubmed
pubmed-article:3657711pubmed:volume15lld:pubmed
pubmed-article:3657711pubmed:ownerNLMlld:pubmed
pubmed-article:3657711pubmed:authorsCompleteYlld:pubmed
pubmed-article:3657711pubmed:pagination216-9lld:pubmed
pubmed-article:3657711pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:meshHeadingpubmed-meshheading:3657711-...lld:pubmed
pubmed-article:3657711pubmed:year1987lld:pubmed
pubmed-article:3657711pubmed:articleTitle131I-metaiodobenzylguanidine treatment in neuroblastoma: report of two cases.lld:pubmed
pubmed-article:3657711pubmed:affiliationNuclear Medicine Service, Ospedale Mauriziano, Torino, Italy.lld:pubmed
pubmed-article:3657711pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3657711pubmed:publicationTypeCase Reportslld:pubmed